As mentioned in last week’s viewpoint, several Brakke consultants including myself participated in the AHNTI conference in London.
The event saw strong attendance, drawing nearly all major animal health companies and much of their senior leadership. Additionally, a wide range of affiliated organizations—including CDMOs, suppliers, and consultants —were present.
The central theme was ‘Innovation,’ explored through a variety of engaging speakers and panel discussions. While innovation is crucial for industry growth, regulatory agencies face ongoing challenges to keep pace and ensure timely approval of new advances to the market. Investment is also a key component, particularly for independent startups, yet there remains a significant shortage of venture capital funding available within animal health to support them.
In my opinion, unless we improve regulatory processes and expand investment opportunities, innovation in animal health will remain more of a discussion point than a reality.
Paul Casady
English 
Portuguese 
Japanese 
Chinese